Pfizer Inc (PFE) has declared a dividend of $0.43 per share, payable to shareholders of record on November 30, 2025. The ex-dividend date is set for November 6, 2025, meaning investors must own shares before this date to qualify for the dividend.
This quarterly dividend reflects Pfizer's ongoing commitment to returning value to shareholders. The current dividend yield stands at 6.90%, calculated based on the company's stock price.
Pfizer, a research-based global biopharmaceutical company headquartered in New York City, employs approximately 81,000 people and focuses on the discovery, development, and distribution of biopharmaceutical products. The company operates in various segments, including oncology, primary care, and specialty care, with a diverse product portfolio that includes well-known medications such as Comirnaty and Eliquis.
As of November 20, 2025, Pfizer's market capitalization is $140.3 billion, with a price-to-earnings ratio of 14.27 and earnings per share of 1.72. Upcoming earnings reports are anticipated on April 27, 2026, and August 3, 2026, with estimated EPS of $0.78 and $0.74, respectively.
Such decisions reflect Pfizer's strategy to maintain a steady income stream for investors while navigating the complexities of the biopharmaceutical market.